Exodus Point Capital Management, LP Tarsus Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 883,043 shares of TARS stock, worth $43.9 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
883,043
Previous 670,459
31.71%
Holding current value
$43.9 Million
Previous $18.2 Million
59.38%
% of portfolio
0.18%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$169 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$162 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$121 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$112 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$110 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.32B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...